These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2024654)

  • 21. Nontraumatic rupture of renal allografts.
    Prompt CA; Johnson WH; Ehrlich RM; Lee DB; Smith RB; Schultze RG
    Urology; 1979 Feb; 13(2):145-8. PubMed ID: 373206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal transplantation in allografts with multiple versus single renal arteries.
    Kamali K; Abbasi MA; Ani A; Zargar MA; Shahrokh H
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):246-50. PubMed ID: 22382214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short- and long-term outcomes of kidney transplants with multiple renal arteries.
    Benedetti E; Troppmann C; Gillingham K; Sutherland DE; Payne WD; Dunn DL; Matas AJ; Najarian JS; Grussner RW
    Ann Surg; 1995 Apr; 221(4):406-14. PubMed ID: 7726677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative preparation of high-risk, specifically hyperimmunized canine renal allograft recipients with total-lymphoid irradiation and cyclosporine.
    Rapaport FT; Meek AG; Arnold AN; Miura S; Hayashi R; Strober S
    Transplantation; 1987 Aug; 44(2):185-95. PubMed ID: 3307042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation.
    First MR; Smith RD; Weiss MA; Schroeder TJ; Kant KS; Munda R; Stephens GW; Penn I; Alexander JW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1567-70. PubMed ID: 2652509
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine.
    Hall BM; Tiller DJ; Duggin GG; Horvath JS; Farnsworth A; May J; Johnson JR; Sheil AG
    Kidney Int; 1985 Aug; 28(2):178-86. PubMed ID: 3914572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine.
    Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S
    Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
    Sumrani N; Delaney V; Ding ZK; Butt K; Hong J
    Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

  • 30. Immediate re-transplantation following early kidney transplant thrombosis.
    Phelan PJ; Magee C; O'Kelly P; J O'Brien F; Little D; Conlon PJ
    Nephrology (Carlton); 2011 Aug; 16(6):607-11. PubMed ID: 21793989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplantation; 1987 Jan; 43(1):65-70. PubMed ID: 3541326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients.
    Henny FC; Kleinbloesem CH; Moolenaar AJ; Paul LC; Breimer DD; van Es LA
    Transplantation; 1985 Sep; 40(3):261-5. PubMed ID: 3898491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years.
    Kahan BD; Flechner SM; Lorber MI; Golden D; Conley S; Van Buren CT
    Transplantation; 1987 Feb; 43(2):197-204. PubMed ID: 3544376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.
    Roth D; Milgrom M; Esquenazi V; Fuller L; Burke G; Miller J
    Transplantation; 1989 Feb; 47(2):278-81. PubMed ID: 2645712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular thrombi in renal allografts associated with cyclosporin treatment.
    Neild GH; Reuben R; Hartley RB; Cameron JS
    J Clin Pathol; 1985 Mar; 38(3):253-8. PubMed ID: 3882763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia.
    Hricik DE; Mayes JT; Schulak JA
    Am J Kidney Dis; 1991 Sep; 18(3):353-8. PubMed ID: 1882828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of cyclosporine on the practice of renal transplantation.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):63-9. PubMed ID: 2545019
    [No Abstract]   [Full Text] [Related]  

  • 40. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
    Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
    Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.